Bactiguard reported Q2 net sales of SEK 48m (SEB at SEK 54m) with organic net sales decline of 9.4% y/y. The organic sales is down only marginally whilst excluding effect of the decision to phase out BIP revenue. Wound management is key driver for the lower sales, however, the company point to healthy growth H1. Q2 EBITDA of SEK 4m was fully in line with SEB (SEK 4m) on what looks like continued strong cost control.
LÄS MER